Viral activation from latency during retrodifferentiation of U937 cells exposed to phorbol ester followed by infection with human immunodeficiency virus type 1.
To determine the mechanism underlying the human immunodeficiency virus type 1 (HIV-1) latency and its activation in monocyte/macrophage lineage, the human promonocytic cell line U937 was infected with HIV-1 after differentiation with varied doses of phorbol 12-myristate 13-acetate (PMA). Variously differentiated intermediate stages were generated in U937 cells in a dose-dependent manner. When these cells were infected with lymphotropic HIV-1, the kinetics of the production of HIV-1 DNA, the appearance of HIV-1 antigen-positive cells, and viral production in the conditioned media were slower at higher doses of PMA. This different susceptibility to the infection was not due to the rate of HIV-1 adsorption. Viral replication from latency in the differentiated cells was activated in proportion with the retrodifferentiation observed in long-term cultures of the host cells. Thus, our data demonstrate the close correlation between the regulation of HIV-1 replication and the differentiation stage of monocyte/macrophage lineage cells at the time of HIV-1 infection. The retrodifferentiation phenomenon in infected cells seems to be particularly important for understanding the mechanisms for HIV-1 activation from latency.
Okada
Y
Y
Institute of Immunological Science, Hokkaido University, Sapporo, Japan.
Kimura
T
T
Kameoka
M
M
Kishi
M
M
Azuma
I
I
Ikuta
K
K
D001483:Base Sequence; D015704:CD4 Antigens / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects / Q000276:immunology; D004305:Dose-Response Relationship, Drug; D015497:HIV-1 / Q000254:growth & development* / Q000276:immunology; D006801:Humans; D007113:Immunity, Innate; D007948:Leukemia, Monocytic, Acute / Q000276:immunology / Q000821:virology; D008969:Molecular Sequence Data; D009000:Monocytes / Q000276:immunology / Q000821:virology; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*; D014407:Tumor Cells, Cultured; D014775:Virus Activation / Q000187:drug effects / Q000276:immunology*
D015704:CD4 Antigens; D013755:Tetradecanoylphorbol Acetate